Provided by Tiger Trade Technology Pte. Ltd.

SBP GROUP

5.650
-0.130-2.25%
Volume:10.98M
Turnover:62.37M
Market Cap:105.91B
PE:37.76
High:5.790
Open:5.780
Low:5.620
Close:5.780
52wk High:9.120
52wk Low:3.778
Shares:18.75B
HK Float Shares:18.75B
Volume Ratio:0.80
T/O Rate:0.06%
Dividend:0.10
Dividend Rate:1.83%
EPS(LYR):0.150
ROE:12.53%
ROA:5.56%
PB:3.00
PE(LYR):37.76
PS:2.89

Loading ...

Assessing Sino Biopharmaceutical (SEHK:1177) Valuation After New GSK Partnership On Hepatitis B Drug Candidate

Simply Wall St.
·
7 hours ago

Sino Biopharmaceutical Stock Rises 2.1% in Hong Kong, Outperforms Competitors

Dow Jones
·
Yesterday

SBP GROUP (01177) Rises Over 3% as Goldman Highlights Hepatitis Portfolio Enhancement with Bepirovirsen Therapy

Stock News
·
Yesterday

Hong Kong Stocks Little Changed as U.S.-Iran Talks Remain Deadlocked; LDROBOT Gains on Debut

MT Newswires Live
·
May 11

Sino Biopharmaceutical Stock Climbs 4.2% in Hong Kong, Outperforms Competitors

Dow Jones
·
May 11

SBP GROUP (01177) Repurchases 1.81 Million Shares for Approximately HK$10.01 Million on May 11

Stock News
·
May 11

Sino Biopharm files HKEX return disclosing share buyback at HKD 5.53 each

Reuters
·
May 11

BUZZ-HK-listed Sino Biopharmaceutical hits 2-week high on GSK tie-up

Reuters
·
May 11

SBP GROUP (01177) Surges Over 4% in Afternoon Session Following Hepatitis B Treatment Collaboration Announcement

Stock News
·
May 11

Sino Biopharmaceutical to Distribute GSK's Hepatitis B Drug in China

MT Newswires Live
·
May 11

SBP GROUP (01177) Enters Exclusive Strategic Partnership with GlaxoSmithKline PLC

Stock News
·
May 11

Sino Biopharma unit CTTQ enters exclusive China bepirovirsen commercialization pact with GSK

Reuters
·
May 11

Sino Biopharmaceutical - Unit to Purchase Bepirovirsen From GSK Under 5.5-Year Supply Agreement

THOMSON REUTERS
·
May 11

Sino Biopharmaceutical - Cttq and GSK May Explore Broader Collaboration on R&D Pipeline Outside China

THOMSON REUTERS
·
May 11

Sino Biopharmaceutical - Unit to Manage Bepirovirsen Sales and Distribution in China; Revenue to Be Recognized by Unit

THOMSON REUTERS
·
May 11

SBP GROUP Shareholder Deposits Shares in Citibank with Custody Value of HK$3.276 Billion

Stock News
·
May 11

SBP GROUP Executes HK$10.055 Million Share Buyback on May 8

Deep News
·
May 09

AI Frenzy Shifts from Hardware to Applications, Musk-Related Concepts Gain Traction

Stock News
·
May 07

Sino Biopharm Unit's Application for Ascites Drug Accepted in China

MT Newswires Live
·
May 07

Sino Biopharm (SBP Group) Keeps Share Base Unchanged, Repurchases 1.85 Million Shares; Cumulative Buybacks Under Mandate at 38.91 Million

Bulletin Express
·
May 07